Home › Idiopathic Thrombocytopenic Purpura › Texas › Houston
Idiopathic Thrombocytopenic Purpura clinical trials in Houston, TX
4 studies for Idiopathic Thrombocytopenic Purpura are looking for participants at sites in and around Houston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia
RecruitingPhase 1/2
- MD Anderson Cancer Center, Houston
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
RecruitingPhase 3
- Baylor College of Medicine, Houston
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
RecruitingPhase 3
- Baylor College of Medicine, Houston
Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
RecruitingPhase 1
- Nerve and Muscle Center of Texas, Houston
Idiopathic Thrombocytopenic Purpura trials in other cities
- Los Angeles, CA7 studies
- Washington, DC6 studies
- Greenville, NC6 studies
- Boston, MA6 studies
- The Bronx, NY5 studies
- Durham, NC4 studies
- Rochester, MN4 studies
- Seattle, WA4 studies
- Portland, OR4 studies
- New Haven, CT3 studies
- Cedar Rapids, IA3 studies
- New Orleans, LA3 studies
Other studies in Houston
- Non-Small Cell Lung Cancer145 studies
- Breast Cancer126 studies
- Cancer (all types)121 studies
- Metastatic Cancer104 studies
- Colorectal Cancer102 studies
- Ovarian Cancer89 studies
- Acute Myeloid Leukemia85 studies
- Lung Cancer78 studies
- Prostate Cancer76 studies
- Endometrial Cancer68 studies
- Pancreatic Cancer61 studies
- Melanoma59 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.